Medical/Pharmaceuticals
Harbour BioMed Announces Dosing of First Patient in Phase I Clinical Study of its Next-Generation Anti-CTLA-4 Antibody in China
SHANGHAI and SUZHOU, China, March 22, 2021 /PRNewswire/ -- Harbour BioMed (HBM) (HKEX: 02142) today announced the dosing of the first patient in its open Phase I clinical study of HBM4003 for Chinese patients suffering from advanced melanoma and other solid tumors (study No. 4003.2). This study w...
2021-03-22 10:31
4554
Airly raises $3.3m from marquee tech investors to address the air quality health crisis
- Problem: More than 10 million people die each year from air pollution - Solution: Airly's sensors and software provide ultra-local, accurate, predictive air quality data to help control air pollution across the world - Traction: Revenue increased over 200% outside the home market in 2020 with ...
2021-03-22 09:00
3951
Antengene to Present Preclinical Data Demonstrating the Synergistic Effect of the Combination of XPO1 and mTORC1/2 Inhibition for the Treatment of Triple-Hit DLBCL at AACR Annual Meeting 2021
SHANGHAI and GAITHERSBURG, Md., March 22, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematolog...
2021-03-22 08:00
2909
Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing
HANGZHOU, China, March 22, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("INF"), a biopharmaceutical innovation and partnership company, announced today the completion of a625M CNY ($96M) Series A financing, which follows a 170M CNY ($24M) Pre-A financing completed in June 2020. The Series A ...
2021-03-22 08:00
4075
Ocumension Therapeutics (1477.HK) Reports Revenue Growth in 2020, National Commercial Construction has been started to become outstanding
HONG KONG, March 20, 2021 /PRNewswire/ -- The Chinese ophthalmology platform company,Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, the "Group" ), (stock code: 1477.HK), announced its annual results for the year ended31 December 2020 today. Ocumension The...
2021-03-20 18:20
8730
Qiming's Portfolio Company Connect Biopharma Lists on Nasdaq
SHANGHAI, March 20, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Connect Biopharma today listed on the Nasdaq with the stock code "CNTB". The issue price isUS$ 17.00/ADS. The stock opened at US$19.55/ADS and closed atUS$18.49/ADS on the first trading day, up 8.8%, with a market...
2021-03-20 09:00
15529
Notice to the Extraordinary General Meeting of Elekta AB (publ)
STOCKHOLM, March 19, 2021 /PRNewswire/ -- Shareholders of Elekta AB (publ), reg. no. 556170-4015, are hereby invited to attend the Extraordinary General Meeting to be held on Friday16 April 2021. Due to the coronavirus pandemic, the Board of Directors has decided that the Meeting should be condu...
2021-03-19 21:30
5803
Everest Medicines to Announce Full-Year 2020 Financial Results on March 22, 2021
SHANGHAI, March 19, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced ...
2021-03-19 14:43
4970
ApiJect Systems, Corp., Announces Appointment of Global Branding Leader, Craig Cohon as Chief Strategy Officer
STAMFORD, Conn., March 19, 2021 /PRNewswire/ -- ApiJect Systems, Corp., a medical technology public benefit corporation that is making prefilled injectors to deliver medicines and vaccines with enormous speed, scale, and efficiency, announced today thatCraig Cohon has been appointed Chief Strateg...
2021-03-19 01:04
2249
MGI Contributes to Africa's COVID-19 Response Efforts
SHENZHEN, China, March 18, 2021 /PRNewswire/ -- MGI
2021-03-18 22:02
2467
BioVaxys Enters Agreement With Inotiv To Conduct Preclinical Toxicity Studies For Its Covid-T™ Immunodiagnostic Program
VANCOUVER, BC, March 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into an agreement with Bioanalytical Systems, Inc. d...
2021-03-18 20:09
4527
WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC Group
SUZHOU, China, March 18, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced it has entered into a purchase agreement with CBC Group ("CBC"), a healthcare-dedicated investment firm, and other compani...
2021-03-18 08:59
3253
Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies
DARMSTADT, Germany, March 17, 2021 /PRNewswire/ -- Merck, a leading science and technology company, will add a single-use assembly production unit at its Life Science Center in Molsheim,France. With the € 25 million investment, the company is accelerating its European expansion plans for this key...
2021-03-17 23:40
3058
Biobohemia Released Paper on the Discovery of the Antigenic Essence of Cancer Cells
BOSTON, March 17, 2021 /PRNewswire/ -- Scientists announced today that they have discovered why they have not succeeded in developing a vaccine against cancer. Vaccination is a powerful tool that has helped us cope with many dangerous diseases, and it is an effective means of combatting the curre...
2021-03-17 20:00
1495
WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China
HANGZHOU, China, March 17, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that it has entered into an equity agreement with Pfizer China ("Pfizer") to acquire its state-of-the-art biologics manu...
2021-03-17 08:45
3208
Cambridge Infinitus Research Centre Made New Research Progress
GUANGZHOU, China, March 17, 2021 /PRNewswire/ -- In 2015, Infinitus co-established Cambridge Infinitus Research Centre with theUniversity of Cambridge. Following five years of great collaboration, the two parties have recently renewed the contract for further exploration. Since its establishment...
2021-03-17 08:00
2277
EDAN Announces 2020 Annual Results and 2025 Outlook: Revenues Increased 104.1%
SHENZHEN, China, March 16, 2021 /PRNewswire/ -- EDAN Instruments, Inc.
2021-03-16 21:37
3731
The remarkable rise of Meenaxi Research Inc.
EDISON, N.J., March 16, 2021 /PRNewswire/ -- Mr. Kaushik Gandhi, the founder of Meenaxi Research Inc. is a pioneer in herbal and allopathic dermatological research. His start-up's unique formulation for atopic dermatitis, has etched an innovative pathway in the medical research industry. Mr. Gan...
2021-03-16 21:00
2052
U-Smell-It LLC Honored in Global $6M XPRIZE Rapid COVID Testing Competition
GUILFORD, Conn., March 16, 2021 /PRNewswire/ -- U-Smell-It™ LLC, a Guilford -based company specializing in innovative COVID detection techniques, has announced that it has won the$6M XPRIZE Rapid COVID Testing, a global effort to develop breakthrough COVID testing methods. XPRIZE Rapid COVID Test...
2021-03-16 21:00
1689
Apollo Hospitals, India becomes the first Asian Hospital to perform four consecutive MitraClip procedures in a day
CHENNAI, India, March 16, 2021 /PRNewswire/ -- The Apollo Hospitals group, one ofAsia's largest and most trusted healthcare group, notched up a record milestone with the successful completion of four consecutive MitraClip procedures in one day. The MitraClip implants were carried out on four pati...
2021-03-16 20:58
2599
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
9236
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7714